日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/10/24 | 3,362 | 3,370 | 3,318 | 3,321 | -61 | -1.8% | 124,700 |
| 2025/10/23 | 3,388 | 3,414 | 3,363 | 3,382 | +13 | +0.4% | 324,300 |
| 2025/10/22 | 3,318 | 3,380 | 3,318 | 3,369 | +78 | +2.4% | 380,700 |
| 2025/10/21 | 3,286 | 3,305 | 3,285 | 3,291 | +1 | ±0% | 105,300 |
| 2025/10/20 | 3,300 | 3,316 | 3,282 | 3,290 | +41 | +1.3% | 203,300 |
| 2025/10/17 | 3,258 | 3,263 | 3,241 | 3,249 | -9 | -0.3% | 127,500 |
| 2025/10/16 | 3,262 | 3,270 | 3,247 | 3,258 | +12 | +0.4% | 102,400 |
| 2025/10/15 | 3,244 | 3,256 | 3,225 | 3,246 | +33 | +1% | 179,300 |
| 2025/10/14 | 3,220 | 3,253 | 3,187 | 3,213 | -71 | -2.2% | 465,300 |
| 2025/10/10 | 3,346 | 3,352 | 3,284 | 3,284 | -103 | -3% | 239,200 |
| 2025/10/09 | 3,305 | 3,387 | 3,300 | 3,387 | +73 | +2.2% | 318,200 |
| 2025/10/08 | 3,316 | 3,341 | 3,307 | 3,314 | -2 | -0.1% | 186,000 |
| 2025/10/07 | 3,310 | 3,345 | 3,297 | 3,316 | -14 | -0.4% | 233,800 |
| 2025/10/06 | 3,330 | 3,365 | 3,311 | 3,330 | +34 | +1% | 336,700 |
| 2025/10/03 | 3,300 | 3,314 | 3,285 | 3,296 | +3 | +0.1% | 289,600 |
| 2025/10/02 | 3,290 | 3,305 | 3,240 | 3,293 | +31 | +1% | 221,100 |
| 2025/10/01 | 3,333 | 3,342 | 3,262 | 3,262 | -71 | -2.1% | 285,300 |
| 2025/09/30 | 3,270 | 3,339 | 3,265 | 3,333 | +68 | +2.1% | 344,500 |
| 2025/09/29 | 3,319 | 3,320 | 3,262 | 3,265 | -102 | -3% | 315,300 |
| 2025/09/26 | 3,339 | 3,409 | 3,320 | 3,367 | +58 | +1.8% | 497,300 |
| 2025/09/25 | 3,320 | 3,328 | 3,303 | 3,309 | -5 | -0.2% | 262,400 |
| 2025/09/24 | 3,340 | 3,340 | 3,306 | 3,314 | -5 | -0.2% | 320,000 |
| 2025/09/22 | 3,329 | 3,332 | 3,302 | 3,319 | -23 | -0.7% | 277,900 |
| 2025/09/19 | 3,390 | 3,408 | 3,330 | 3,342 | +32 | +1% | 722,300 |
| 2025/09/18 | 3,331 | 3,340 | 3,301 | 3,310 | +11 | +0.3% | 181,000 |
| 2025/09/17 | 3,330 | 3,350 | 3,299 | 3,299 | -40 | -1.2% | 236,500 |
| 2025/09/16 | 3,290 | 3,348 | 3,284 | 3,339 | +46 | +1.4% | 218,400 |
| 2025/09/12 | 3,302 | 3,310 | 3,277 | 3,293 | -4 | -0.1% | 210,500 |
| 2025/09/11 | 3,295 | 3,310 | 3,271 | 3,297 | -2 | -0.1% | 192,900 |
| 2025/09/10 | 3,302 | 3,321 | 3,289 | 3,299 | -3 | -0.1% | 175,000 |
| 2025/09/09 | 3,368 | 3,386 | 3,302 | 3,302 | -78 | -2.3% | 290,000 |
| 2025/09/08 | 3,328 | 3,384 | 3,307 | 3,380 | +86 | +2.6% | 332,400 |
| 2025/09/05 | 3,260 | 3,301 | 3,250 | 3,294 | +24 | +0.7% | 307,900 |
| 2025/09/04 | 3,276 | 3,276 | 3,233 | 3,270 | +3 | +0.1% | 194,800 |
| 2025/09/03 | 3,230 | 3,287 | 3,226 | 3,267 | +47 | +1.5% | 491,400 |
| 2025/09/02 | 3,235 | 3,286 | 3,220 | 3,220 | ±0 | ±0% | 519,000 |
| 2025/09/01 | 3,174 | 3,225 | 3,161 | 3,220 | +93 | +3% | 664,100 |
| 2025/08/29 | 3,110 | 3,142 | 3,107 | 3,127 | +32 | +1% | 315,900 |
| 2025/08/28 | 3,098 | 3,119 | 3,075 | 3,095 | -35 | -1.1% | 416,400 |
| 2025/08/27 | 3,142 | 3,144 | 3,117 | 3,130 | -23 | -0.7% | 267,500 |
| 2025/08/26 | 3,210 | 3,210 | 3,146 | 3,153 | -69 | -2.1% | 386,300 |
| 2025/08/25 | 3,245 | 3,273 | 3,211 | 3,222 | -4 | -0.1% | 205,900 |
| 2025/08/22 | 3,211 | 3,235 | 3,192 | 3,226 | +4 | +0.1% | 219,900 |
| 2025/08/21 | 3,240 | 3,244 | 3,215 | 3,222 | -25 | -0.8% | 262,800 |
| 2025/08/20 | 3,286 | 3,293 | 3,247 | 3,247 | -40 | -1.2% | 293,700 |
| 2025/08/19 | 3,261 | 3,288 | 3,243 | 3,287 | +16 | +0.5% | 264,700 |
| 2025/08/18 | 3,255 | 3,296 | 3,250 | 3,271 | +28 | +0.9% | 376,600 |
| 2025/08/15 | 3,251 | 3,264 | 3,215 | 3,243 | -23 | -0.7% | 283,100 |
| 2025/08/14 | 3,323 | 3,335 | 3,256 | 3,266 | -57 | -1.7% | 348,400 |
| 2025/08/13 | 3,334 | 3,342 | 3,287 | 3,323 | -11 | -0.3% | 315,800 |
1～
50
件表示中 / 3810件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 333,600円 | +3.6% | -15.3% | 3.72% | 9.37倍 | 0.91倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 久光薬 | 405,200円 | +5.8% | +1.2% | 2.96% | 13.03倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 367,500円 | +3.8% | -19.9% | 3.70% | 11.93倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 191,900円 | +5.9% | +684.6% | 2.87% | 12.73倍 | 1.27倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 164,350円 | +5.0% | +1.5% | 0.00% | 14.06倍 | 3.95倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
